Suppr超能文献

加拿大艾滋病患者中的播散性日内瓦分枝杆菌感染

Disseminated Mycobacterium genavense infection in Canadian AIDS patients.

作者信息

Shafran S D, Taylor G D, Talbot J A

机构信息

Department of Medicine, University of Alberta, Edmonton, Canada.

出版信息

Tuber Lung Dis. 1995 Apr;76(2):168-70. doi: 10.1016/0962-8479(95)90562-6.

Abstract

Mycobacterium genavense is a recently described mycobacterial species which thus far has been identified only in persons with advanced HIV disease. It appears to be a rare pathogen with an undefined reservoir. We describe the first two cases of M. genavense infection in Canadian AIDS patients. The clinical presentation of fever and wasting with extremely low CD4 lymphocyte counts was indistinguishable from disseminated M. avium complex (MAC) infection. However, blood cultures in BACTEC 13A medium required a mean of 58 days (range 41-87) to detect growth of M. genavense in contrast to a mean of 10 days for MAC in our laboratory. M. genavense infection is underdiagnosed due to the lack of universal use of BACTEC liquid medium and the use of relatively short incubation times (only 6 weeks) by some laboratories. The value of antimycobacterial therapy for M. genavense is unknown, but anecdotal data suggest that treatment with a regimen appropriate for MAC may be beneficial.

摘要

日内瓦分枝杆菌是一种最近才被描述的分枝杆菌菌种,迄今为止仅在晚期艾滋病患者中被鉴定出来。它似乎是一种罕见的病原体,其储存宿主尚不明确。我们描述了加拿大艾滋病患者中首例两例日内瓦分枝杆菌感染病例。发热和消瘦伴极低的CD4淋巴细胞计数的临床表现与播散性鸟分枝杆菌复合群(MAC)感染难以区分。然而,在BACTEC 13A培养基中进行血培养,检测到日内瓦分枝杆菌生长平均需要58天(范围41 - 87天),而在我们实验室中,MAC平均需要10天。由于未普遍使用BACTEC液体培养基以及一些实验室使用相对较短的培养时间(仅6周),日内瓦分枝杆菌感染的诊断不足。抗分枝杆菌治疗对日内瓦分枝杆菌的价值尚不清楚,但轶事数据表明,使用适合MAC的方案进行治疗可能有益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验